Author: UCSC Public Affairs
-
Police Department arrests suspect in voyeurism and theft investigations on campus
The UC Santa Cruz Police Department has arrested a suspect in connection with multiple campus incidents that occurred between February and May 2025.
-
In Memoriam: Michael Cowan
Michael Cowan joined UC Santa Cruz in 1969, just four years after the university opened, bringing with him a passion for American studies, literature, and the arts.
-
CITRIS invites applications for research support through Interdisciplinary Innovation Program (I2P)
CITRIS and the Banatao Institute at UC Santa Cruz invite UC Santa Cruz principal investigators to apply for research support through the Interdisciplinary Innovation Program (I2P), previously known as the CITRIS UCSC Campus Seed Funding Program.
-
UC Santa Cruz Police, students collaborate on innovative crime visualization dashboard
Users can view categorized crime data, time trends, and geographic mapping of reported crimes and incidents—features that enhance both public awareness and efforts to strengthen community safety.
-
UC seeks input on Academic Planning Calendar report
The report summarizes key findings on existing and potential calendar structures, a proposed alternate quarter calendar, and important factors to consider before any changes are made.
-
Interviews for Vice Provost of Academic Affairs
Campus leadership invites all in the UC Santa Cruz community to participate in the interview process and provide feedback on the three candidates.
-
Decline of large carnivores creates dire environmental ripple effect
UC Santa Cruz environmental researchers contributed to an analysis of 31 carnivore species that shows for the first time how habitat loss, persecution by humans, and loss of prey combine to create global hotspots of carnivore decline.
-
Gene patent decision called step forward for open research
Genetics researchers at UC Santa Cruz said the U.S. Supreme Court’s unanimous ruling that human genes cannot be patented will help keep advanced genetic research from being controlled by private biotechnology companies.